The next-generation Visiflex Delivery System from Endologix is FDA approved to be marketed for use with the Powerlink system for the minimally invasive treatment of abdominal aortic aneurysms. Full U.S. commercialization is anticipated this fall.
The Visiflex Delivery System is designed to provide improved catheter flexibility for delivery of the Powerlink endoluminal stent graft. The device features an integrated radiopaque band marker on the outer sheath and molded component parts that are designed to enhance catheter visibility and facilitate smoother withdrawal in difficult anatomies. In Europe, the Visiflex is CE marked and has been successfully used in Powerlink procedures.